Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health disorders, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania published this week in JAMA Internal Medicine.
Burdensome Therapy for Severe Hypoxemia in COPD Patients Is Overkill, Trial Says
The decades-long practice of prescribing long-term oxygen for 24 hours a day to patients with severe hypoxemia from chronic lung diseases appears unnecessary, according to